OmicVision Biosciences ApS

CVR 44285584 · Private limited company (ApS) · Active · Medium risk

OmicVision Biosciences ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.9% over the next 12 months, which is 1.3 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 117k and a net result of DKK -4.4m. CEO: Andreas Mund, Maximilian Thomas Dr Strauss.

Bankruptcy risk for OmicVision Biosciences ApS

1.9%
probability of bankruptcy within 12 months
Medium risk

1.3 × the average (1.41%) · higher risk than 82% of active Danish companies

Lowest riskHighest risk

Increases the risk

Published annual reports2 · bankruptcy rate 16.7%1.9×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×

Reduces the risk

Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Capital changes2 · bankruptcy rate 5.2%0.59×
Registered owners4+ · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44285584
Status
Active
Company type
Private limited company (ApS)
Founded
(3 years)
Address
c/o OmicVision Biosciences ApS, Ryesgade 113
2100 København Ø
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 51k
Auditor
DANSK REVISION ODENSE GODKENDT REVISIONSAKTIESELSKAB
Audit opted out
No

Warning signs

Annual reports filed late0 of 2
Missing annual reportNo
Negative equityNo
Equity ratio1.0%
Current ratio472%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address3
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 3.6mDKK 1.5m
Net profitDKK -4.4mDKK -3.0m
EquityDKK 117kDKK 4.5m
Total assetsDKK 12.3mDKK 5.5m
CashDKK 5.4m–
Short-term debtDKK 2.6m–
Avg. employees9–

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Dansk Revision Odense.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025133
1 Sep 2023 – 31 Dec 2024177

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOAndreas MundCurrent
CEOMaximilian Thomas Dr StraussCurrent
BoardOle VormCurrent
BoardAndreas MundCurrent
BoardMaximilian Thomas Dr StraussCurrent
Owner (33%)VOMA HOLDING A/SCurrent
Owner (15%)AM Tech Ventures ApSCurrent
Owner (15%)MS Ventures ApSCurrent
Owner (10%)Ummat Ventures ApSCurrent
Owner (50%)AM Tech Ventures ApS
Owner (50%)MS Ventures ApS
Owner (50%)VOMA HOLDING A/S
Owner (20%)AM Tech Ventures ApS
Owner (20%)MS Ventures ApS
AuditorDANSK REVISION ODENSE GODKENDT REVISIONSAKTIESELSKABCurrent
FounderAM Tech Ventures ApSCurrent
FounderMS Ventures ApSCurrent

The CEOs' other companies

Andreas Mund – 1 other companies

Maximilian Thomas Dr Strauss – 1 other companies

Address history (2 moves)

c/o OmicVision Biosciences ApS, Ryesgade 113, 2100 København Ø
c/o OmicVision Biosciences ApS, Ole Maaløes Vej 3, 1., 2200 København N
Kildemosevej 18, 3060 Espergærde

Other companies at the same address

Similar companies in København

Questions and answers about OmicVision Biosciences ApS

Has OmicVision Biosciences ApS gone bankrupt?

No, OmicVision Biosciences ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of OmicVision Biosciences ApS?

Our model estimates a bankruptcy risk of 1.9% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.

Who is the CEO of OmicVision Biosciences ApS?

Andreas Mund, Maximilian Thomas Dr Strauss are the CEOs of OmicVision Biosciences ApS.

Who is the auditor of OmicVision Biosciences ApS?

OmicVision Biosciences ApS most recently used DANSK REVISION ODENSE GODKENDT REVISIONSAKTIESELSKAB.

When was OmicVision Biosciences ApS founded?

OmicVision Biosciences ApS was founded on 1 September 2023.

What is the equity of OmicVision Biosciences ApS?

Equity was DKK 117k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.